Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera

S. Temerinac, Steffen Klippel, Elisabeth Strunck, +7

Blood

Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit thein vitro growth of human head and neck cancer cells and cause rapid tumor regressionin vivo

Marc Azémar, Mathias Schmidt, Friederike Arlt, +5

International Journal of Cancer

Regression of Cutaneous Tumor Lesions in Patients Intratumorally Injected with a Recombinant Single-chain Antibody-toxin Targeted to ErbB2/HER2

Marc Azémar, S. Djahansouzi, Elke Jäger, +9

Breast Cancer Research and Treatment

MedicineImmunoeditingPathologyCutaneous Tumor LesionsTumor Targeting +5

Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases

Gerhard J. Molderings, Martin Raithel, Felix Kratz, +4

Internal Medicine

Systemic McadTranslational MedicineAllergyAutoimmune DiseaseTherapeutic Option +13

c-kit (CD117) Expression in Human Tumors and its Prognostic Value: An Immunohistochemical Analysis

Michael Medinger, M. Kleinschmidt, K. Mross, +5

Pathology & Oncology Research

Human TumorsMedicinePrognostic ValueImmunologyPathology +8

Clinical Benefit in Patients with Advanced Solid Tumors Treated with Modified Citrus Pectin: A Prospective Pilot Study

Marc Azémar, Bernd Hildenbrand, B Haering, +2

Clinical medicine Oncology

Citrus PectinSurgical OncologyPilot TrialChemoprevention StrategyGastrointestinal Oncology +12

Tumour Biology: tumour-associated inflammation versus antitumor immunity.

Boris Müller-Hübenthal, Marc Azémar, D. Lorenzen, +5

PubMed

Tumour FormationImmunologyImmune RegulationPathologyImmunotherapy +14

Treatment of Anthracycline Extravasation with Dexrazoxane – Clinical Experience

Annette Frost, Daniela Gmehling, Marc Azémar, +2

Oncology Research and Treatment

Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera

S. Temerinac, Steffen Klippel, Elisabeth Strunck, +7

Blood

IFN-y enhances T(H)1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions.

Bernd Hildenbrand, D. Lorenzen, Barbara Sauer, +5

PubMed

Adaptive Immune SystemCytokine-matured ModcsImmunologyImmune RegulationPathology +17